Cargando…

Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59

The Ly-6 superfamily of cell surface molecules includes CD59, a potent regulator of the complement system that protects host cells from the cytolytic action of the membrane attack complex (MAC). Although its mechanism of action is not well understood, CD59 is thought to prevent assembly of the MAC b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodian, Dale L., Davis, Simon J., Morgan, B. Paul, Rushmere, Neil K.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196035/
https://www.ncbi.nlm.nih.gov/pubmed/9053451
_version_ 1782147981369147392
author Bodian, Dale L.
Davis, Simon J.
Morgan, B. Paul
Rushmere, Neil K.
author_facet Bodian, Dale L.
Davis, Simon J.
Morgan, B. Paul
Rushmere, Neil K.
author_sort Bodian, Dale L.
collection PubMed
description The Ly-6 superfamily of cell surface molecules includes CD59, a potent regulator of the complement system that protects host cells from the cytolytic action of the membrane attack complex (MAC). Although its mechanism of action is not well understood, CD59 is thought to prevent assembly of the MAC by binding to the C8 and/or C9 proteins of the nascent complex. Here a systematic, structure-based mutational approach has been used to determine the region(s) of CD59 required for its protective activity. Analysis of 16 CD59 mutants with single, highly nonconservative substitutions suggests that CD59 has a single active site that includes Trp-40, Arg-53, and Glu-56 of the glycosylated, membrane-distal face of the disk-like extracellular domain and, possibly, Asp-24 positioned at the edge of the domain. The putative active site includes residues conserved across species, consistent with the lack of strict homologous restriction previously observed in studies of CD59 function. Competition and mutational analyses of the epitopes of eight CD59-blocking and non-blocking monoclonal antibodies confirmed the location of the active site. Additional experiments showed that the expression and function of CD59 are both glycosylation independent.
format Text
id pubmed-2196035
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21960352008-04-22 Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59 Bodian, Dale L. Davis, Simon J. Morgan, B. Paul Rushmere, Neil K. J Exp Med Article The Ly-6 superfamily of cell surface molecules includes CD59, a potent regulator of the complement system that protects host cells from the cytolytic action of the membrane attack complex (MAC). Although its mechanism of action is not well understood, CD59 is thought to prevent assembly of the MAC by binding to the C8 and/or C9 proteins of the nascent complex. Here a systematic, structure-based mutational approach has been used to determine the region(s) of CD59 required for its protective activity. Analysis of 16 CD59 mutants with single, highly nonconservative substitutions suggests that CD59 has a single active site that includes Trp-40, Arg-53, and Glu-56 of the glycosylated, membrane-distal face of the disk-like extracellular domain and, possibly, Asp-24 positioned at the edge of the domain. The putative active site includes residues conserved across species, consistent with the lack of strict homologous restriction previously observed in studies of CD59 function. Competition and mutational analyses of the epitopes of eight CD59-blocking and non-blocking monoclonal antibodies confirmed the location of the active site. Additional experiments showed that the expression and function of CD59 are both glycosylation independent. The Rockefeller University Press 1997-02-03 /pmc/articles/PMC2196035/ /pubmed/9053451 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Bodian, Dale L.
Davis, Simon J.
Morgan, B. Paul
Rushmere, Neil K.
Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title_full Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title_fullStr Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title_full_unstemmed Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title_short Mutational Analysis of the Active Site and Antibody Epitopes of the Complement-inhibitory Glycoprotein, CD59
title_sort mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, cd59
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196035/
https://www.ncbi.nlm.nih.gov/pubmed/9053451
work_keys_str_mv AT bodiandalel mutationalanalysisoftheactivesiteandantibodyepitopesofthecomplementinhibitoryglycoproteincd59
AT davissimonj mutationalanalysisoftheactivesiteandantibodyepitopesofthecomplementinhibitoryglycoproteincd59
AT morganbpaul mutationalanalysisoftheactivesiteandantibodyepitopesofthecomplementinhibitoryglycoproteincd59
AT rushmereneilk mutationalanalysisoftheactivesiteandantibodyepitopesofthecomplementinhibitoryglycoproteincd59